ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,01%
Bitcoin
67.627,42
0,22%
Brent Oil
81,295
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Guardant Health Inc (GH)

  7. Guardant Health Inc (GH) Notícias

GH

Guardant Health (GH)

Guardant Health Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:GH
DataHoraFonteTítuloCódigoCompanhia
31/05/202417:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GHGuardant Health Inc
31/05/202409:05Business WireGuardant Health Named to TIME100 Most Influential CompaniesNASDAQ:GHGuardant Health Inc
30/05/202409:05Business WireGuardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer ScreeningNASDAQ:GHGuardant Health Inc
23/05/202420:03Business WireFDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening OptionNASDAQ:GHGuardant Health Inc
23/05/202408:05Business WireGuardant Health Stock Trading Temporarily Halted; FDA Panel to Assess Premarket Approval Application for Shield Blood Test for Colorectal Cancer ScreeningNASDAQ:GHGuardant Health Inc
22/05/202417:05Business WireGuardant Health to Participate in Upcoming Investor ConferencesNASDAQ:GHGuardant Health Inc
21/05/202409:44Business WireGuardant Health reçoit la certification IVDR de l’UE pour la biopsie liquide Guardant360® CDx destinée au profilage des mutations tumorales dans tous les cancers solides et les indications de diagnostic compagnonNASDAQ:GHGuardant Health Inc
21/05/202409:44Business WireGuardant Health erhält EU-IVDR-Zertifizierung für Flüssigbiopsie Guardant360® CDx zur Erstellung von Tumormutationsprofilen für alle soliden Krebsarten und therapiebegleitende Diagnostika-IndikationenNASDAQ:GHGuardant Health Inc
21/05/202409:05Business WireGuardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic IndicationsNASDAQ:GHGuardant Health Inc
17/05/202409:05Business WireGuardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GHGuardant Health Inc
16/05/202419:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
16/05/202409:05Business WireGuardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease WeekNASDAQ:GHGuardant Health Inc
09/05/202417:59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GHGuardant Health Inc
09/05/202417:05Business WireGuardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue GuidanceNASDAQ:GHGuardant Health Inc
07/05/202409:00Business WireGuardant Health Surpasses 500 Peer-Reviewed Publications MilestoneNASDAQ:GHGuardant Health Inc
22/04/202409:52Business WireFDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23NASDAQ:GHGuardant Health Inc
18/04/202417:05Business WireGuardant Health to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:GHGuardant Health Inc
03/04/202409:05Business WireGuardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual MeetingNASDAQ:GHGuardant Health Inc
13/03/202418:00Business WireGuardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of MedicineNASDAQ:GHGuardant Health Inc
04/03/202419:53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GHGuardant Health Inc
01/03/202407:30Business WireNew Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening GapNASDAQ:GHGuardant Health Inc
23/02/202418:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GHGuardant Health Inc
22/02/202419:23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GHGuardant Health Inc
22/02/202418:05Business WireGuardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 OutlookNASDAQ:GHGuardant Health Inc
13/02/202421:46Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
01/02/202418:05Business WireGuardant Health to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024NASDAQ:GHGuardant Health Inc
18/01/202419:09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
17/01/202410:05Business WireGuardant Health to present data at ASCO GI supporting use of liquid biopsy to predict colon cancer recurrenceNASDAQ:GHGuardant Health Inc
08/01/202411:00Business WireGuardant Health Announces Preliminary Fourth Quarter and Full Year 2023 ResultsNASDAQ:GHGuardant Health Inc
08/01/202404:30PR Newswire (US)Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North AfricaNASDAQ:GHGuardant Health Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:GH

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
CIEL3
CIELO ON
BOV
PRIO3
PETRORIO ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
SGPS3
SPRINGS ON
BOV
RCSL3
RECRUSUL ON
BOV
TECN3
TECHNOS ON
BOV
TPIS3
TRIUNFO PART ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados